Similar results were obtained for FTD, where truncated STMN2 seems to be a marker for TDP-43 dysfunction in FTD (but not for other pathological phenotypes, such as FTLD-tau) [243]. The gene discussed is MAPT; the disease is frontotemporal dementia.